• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dermata Therapeutics Inc (NQ: DRMA )

    1.530 -0.110 (-6.71%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 159,327
    Open 1.590
    Bid (Size) 1.560 (5)
    Ask (Size) 1.620 (45)
    Prev. Close 1.640
    Today's Range 1.460 - 1.660
    52wk Range 0.2320 - 5.790
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    Via ACCESSWIRE
    Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Performance

    YTD
    +159.28%
    +159.28%
    1 Month
    -4.38%
    -4.38%
    3 Month
    -33.19%
    -33.19%
    6 Month
    +266.91%
    +266.91%
    1 Year
    +47.12%
    +47.12%

    More News

    Read More
    Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    Via ACCESSWIRE
    Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Peering Into Dermata Therapeutics's Recent Short Interest
    Via Benzinga
    Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
    Via ACCESSWIRE
    Why Is Dermata Therapeutics (DRMA) Stock Up 200% Today?
    Via InvestorPlace
    Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
    Via ACCESSWIRE
    Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    7 F-Rated Growth Stocks to Avoid Like the Plague in August 2024
    Via InvestorPlace
    Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
    Via ACCESSWIRE
    DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Dermata Therapeutics Shares Are Trading Over 100%: What You Need To Know
    Via Benzinga
    Nasdaq Down 2%; Alphabet Posts Upbeat Earnings
    Via Benzinga
    Why Is Azitra (AZTR) Stock Down 75% Today?
    Via InvestorPlace
    Topics Intellectual Property
    Exposures Intellectual Property
    Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Is Nuzee (NUZE) Stock Up 133% Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
    Via ACCESSWIRE
    DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.